Research / ORCL / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-18-201034 General Corporate
Capex intensity 44th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.36% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
38.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
5.57% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
1.00% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
60.98% · CORE · NOT_ENOUGH_HISTORY
Operating margin 89th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
34.34% · CORE · VALID
R&D intensity 0th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.29% · OPTIONAL · VALID
SBC intensity 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.03% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Nov 30, 2021 6/6 normalized Level 3 Feb 28, 2022 6/6 normalized Level 3 May 31, 2022 7/8 normalized Level 3 Aug 31, 2022 6/6 normalized Level 3 Nov 30, 2022 6/6 normalized Level 3 Feb 28, 2023 6/6 normalized Level 3 May 31, 2023 7/7 normalized Level 3 Aug 31, 2023 6/6 normalized Level 3 Nov 30, 2023 6/6 normalized Level 3 Feb 29, 2024 6/6 normalized Level 3 May 31, 2024 7/7 normalized Level 3 Aug 31, 2024 6/6 normalized Level 3 Nov 30, 2024 6/6 normalized Level 3 Feb 28, 2025 6/6 normalized Level 3 May 31, 2025 7/7 normalized Level 3 Aug 31, 2025 6/6 normalized Level 3 Nov 30, 2025 6/6 normalized Level 3 Feb 28, 2026 6/6 normalized Level 3 May 31, 2026 6/6 normalized Level 3 Aug 31, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 2.93%
Current 4.36%
Delta 1.43% Growth Decreased
Previous 6.15%
Current 5.57%
Delta -0.57% Inventory Pressure Decreased
Previous 5.08%
Current 1.00%
Delta -4.08% Margin Decreased
Previous 61.08%
Current 60.98%
Delta -0.10% Profitability Decreased
Previous 34.90%
Current 34.34%
Delta -0.56% R And D Intensity Decreased
Previous 15.33%
Current 15.29%
Delta -0.04% Sbc Intensity Increased
Previous 3.98%
Current 4.03%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.